PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
27055778-6	2016	Phosphorylated-fingolimod was shown in vitro to reduce S1PR1 RNA and protein, to slightly increase viability and to activate anti-apoptotic Bcl2 in transformed B cells of patients with MS.	Fingolimod Hydrochloride	15-25	BCL2 apoptosis regulator	Homo sapiens	140-144	
25344679-9	2014	Western blot analysis showed that FTY720 induced cleavage of caspases 3, 8 and 9, and of PARP, in a dose-dependent manner, consistent with a substantial decrease in p-STAT3, Bcl-xL, Bcl-2, survivin, cyclin D1, cyclin E, N-cadherin, vimentin, VEGF and TWIST1.	Fingolimod Hydrochloride	34-40	BCL2 apoptosis regulator	Homo sapiens	182-187	
30623407-3	2019	It was disclosed that FTY-720 significantly stimulates Bcl2 overexpression.	Fingolimod Hydrochloride	22-29	BCL2 apoptosis regulator	Homo sapiens	55-59